Community-Based Interventions for Marginalized Populations

Mitty, Jennifer Adelson; Flanigan, Timothy P.
June 2004
Clinical Infectious Diseases;6/1/2004 Supplement, Vol. 38, pS373
Academic Journal
This article presents information on the community based interventions for AIDS patient's care. Combination antiretroviral therapy has led to dramatic reductions in morbidity and mortality among patients with HIV/AIDS, including those who present with advanced AIDS and very low CD4+ cell counts. Unfortunately, many HIV-in-infected persons have not realized the benefits of HAART because of difficulties in accessing care or an inability to adhere to medications. The majority of these persons are active substance users, have mental health disorders, or cope with social instability, such as homelessness. It is now recognized that innovative approaches are needed to increase access and adherence to HAART, especially among these hard-to-reach populations.


Related Articles

  • Free HIV/AIDS treatment plans kick off in S Africa, China.  // PharmacoEconomics & Outcomes News;5/8/2004, Issue 452, p11 

    Reports on the decision of the South Africa government to administer free antiretrovirals to patients with AIDS. Delay on the launch of the plan due to lack of physicians; Prevention of mother-to-child transmission of HIV under the policy.

  • HIV and Hyperlipidemia: Current Recommendations And Treatment. Capili, Bernadette; Anastasi, Joyce K. // MEDSURG Nursing;Feb2006, Vol. 15 Issue 1, p14 

    The article discusses the Highly Active Antiretroviral Therapies (HAART) as a big factor in fighting HIV and AIDS. Cardiovascular disease is also recognized as one of the subsequent diseases which is a result from AIDS virus. It was found out that this life threatening condition has now become...

  • Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. Young, Jim; Bucher, Heiner C.; Battegay, Manuel; De Geest, Sabina; Spirig, Rebecca; Flepp, Markus; Rickenbach, Martin; Furrer, Hansjakob; Bernasconi, Enos; Hirschel, Bernard; Telenti, Amalio; Vernazza, Pietro // BMJ: British Medical Journal (International Edition);1/3/2004, Vol. 328 Issue 7430, p15 

    Presents a paper on stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy.

  • Retrospective Analysis of Suspending HAART in Selected Patients with Controlled HIV Replication. Jacobs, Benjamin; Neil, Nancy; Aboulafia, David M. // AIDS Patient Care & STDs;Jul2005, Vol. 19 Issue 7, p429 

    We sought to determine the consequences of stopping highly active antiretroviral therapy (HAART) in a group of 41 HIV-infected individuals with undetectable HIV viral loads and CD4+ counts greater than 500 cells per microliter for 6 months or more. Clinical and laboratory parameters were...

  • HAART: A Cost-Effective Option for South Africa.  // PLoS Medicine;Jan2006, Vol. 3 Issue 1, pe37 

    The article presents information on a study on the use of highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS patients in South Africa. The researchers compared the cost of services for a number of patients who were given HAART with the costs for a matched comparison group...

  • Structured Intermittent Therapy with Seven-Day Cycles of HAART for Chronic HIV Infection: A Pilot Study in São Paulo, Brazil. Casseb, Jorge; Da Silva Duarte, Alberto Jos // AIDS Patient Care & STDs;Jul2005, Vol. 19 Issue 7, p425 

    In the last 6 years, an impressive impact of the highly active antiretroviral therapy (HAART) on survival and morbidity in HIV-1–infected individuals has been attained. However, their prolonged use may induce metabolic adverse effects such as lipodistrophy, hypertension, diabetes...

  • Improving Outcomes in Infants of HIV-Infected Women in a Developing Country Setting. Noel, Francine; Mehta, Sapna; Yuwei Zhu; de Matteis Rouzier, Patricia; Marcelin, Abdias; Shi, Jian R.; Nolte, Claudine; Severe, Linda; Deschamps, Marie Marcelle; Fitzgerald, Daniel W.; Johnson, Warren D.; Wright, Peter F.; Pape, Jean W. // PLoS ONE;2008, Vol. 3 Issue 11, p1 

    Background: Since 1999 GHESKIO, a large voluntary counseling and HIV testing center in Port-au-Prince, Haiti, has had an ongoing collaboration with the Haitian Ministry of Health to reduce the rate of mother to child HIV transmission. There are limited data on the ability to administer complex...

  • Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans Frontières. O'Brien, Daniel P.; Venis, Sarah; Greig, Jane; Shanks, Leslie; Ellman, Tom; Sabapathy, Kalpana; Frigati, Lisa; Mills, Clair // Conflict & Health;2010, Vol. 4, p12 

    Introduction: Many countries ravaged by conflict have substantial morbidity and mortality attributed to HIV/AIDS yet HIV treatment is uncommonly available. Universal access to HIV care cannot be achieved unless the needs of populations in conflict-affected areas are addressed. Methods: From 2003...

  • Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort Study. Lescure, Françxois-Xavier; Omland, Lars Haukali; Engsig, Frederik Neess; Roed, Casper; Gerstoft, Jan; Pialoux, Gilles; Kronborg, Gitte; Larsen, Carsten Schade; Obel, Niels // Clinical Infectious Diseases;1/15/2011, Vol. 52 Issue 2, p235 

    Objective. The risk of neurocognitive disorders in human immunodefiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART) is controversial. We aimed to compare the incidence and impact on mortality of severe neurocognitive disorders (SNCDs) in HIV-infected...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics